Methods and compositions for vitamin K epoxide reductase
US7482141B2 · kind B2 · utility
12Cited by
11References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2007 |
| Grant date | Jan 27, 2009 |
| Priority date | — |
| Expiry date | Jan 30, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/172
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides a method of identifying a human subject having increased or decreased sensitivity to warfarin, comprising detecting in the subject the presence of a single nucleotide polymorphism in the VKOR gene, wherein the single nucleotide polymorphism is correlated with increased or decreased sensitivity to warfarin, thereby identifying the subject having increased or decreased sensitivity to warfarin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.